SO
BMY.RT

STRS Ohio’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

STRS Ohio’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,861
Closed -$6K – 2348
2020
Q4 		$6K Hold
8,861
– – ﹤0.01% 2128
2020
Q3 		$19K Hold
8,861
– – ﹤0.01% 2095
2020
Q2 		$31K Sell
8,861
-126,800
-93% -$457K ﹤0.01% 1982
2020
Q1 		$515K Hold
135,661
– – ﹤0.01% 1108
2019
Q4 		$408K Buy
+135,661
New +$353K ﹤0.01% 1512

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

STRS Ohio's BMY.RT Position: Q1 2021 in Review

STRS Ohio sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 8,861 shares — an estimated $6K sold.

STRS Ohio first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $515K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • STRS Ohio reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • STRS Ohio sold 8,861 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $6K.
  • STRS Ohio first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • STRS Ohio's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $515K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.